Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
LG Chem clinical trials
The registry lists 184 studies whose lead sponsor is LG Chem or one of 2 companies grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Keep track of what changes. Save the LG Chem studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to LG Chem.
- 78 studies →
- LG Chem71 studiesSame company
Something wrong?
- AVEO Pharmaceuticals, Inc.35 studies →Acquired — became part of LG Chem, Jan 19, 2023 · source ↗
Something wrong?
Focus areas
Conditions LG Chem leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 184. Browse all 184 →
- OLE Study Subsequent to Parent Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCNot yet recruitingNCT07888075Phase 2/3
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted after AVEO Pharmaceuticals, Inc. became part of LG Chem
- Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil CapsuleRecruitingNCT06206135
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
- A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious PubertyRecruitingNCT07710430Phase 4
- A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell CarcinomaRecruitingNCT06064877Phase 3
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted after AVEO Pharmaceuticals, Inc. became part of LG Chem
- A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaRecruitingNCT05865535Phase 1
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted after AVEO Pharmaceuticals, Inc. became part of LG Chem
- Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCRecruitingNCT06332755Phase 1
- Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeNot yet recruitingNCT06618196Phase 2
- A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic ObesityNot yet recruitingNCT06041841Phase 2
- A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy AdultsNot yet recruitingNCT05952596Phase 1
- Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in ChildrenRecruitingNCT01604395
- The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy VolunteersCompletedNCT07396844Phase 1
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/3
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/3
- Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).Active, not recruitingNCT06921395Phase 4
- A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.CompletedNCT07399470Phase 1
- Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell CarcinomaCompletedNCT04987203Phase 3
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted before AVEO Pharmaceuticals, Inc. became part of LG Chem
- Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus PatientsCompletedNCT06495281
- A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a MealCompletedNCT07333742Phase 1
- A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With HyperuricemiaCompletedNCT03934099Phase 2
- Tigulixostat, Phase 3 Study, Placebo Controlled in Gout PatientsCompletedNCT05586958Phase 3
- Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout PatientsCompletedNCT05586971Phase 3
- A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and TolerabilityCompletedNCT06743997Phase 1
- Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in InfantsCompletedNCT05431933Phase 3
- Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in ChinaCompletedNCT05314504Not applicable
- To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face VolumeCompletedNCT04784299Not applicable
- Effectiveness and Safety of YVOIRE Y-Solution 540CompletedNCT04855188Not applicable
- A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OACompletedNCT05237752Phase 1/2
- A Study of LC542019 in Healthy Subjects and Subjects With T2DMCompletedNCT06333977Phase 1
- To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-FaceCompletedNCT04437745Not applicable
- Effect of Tigulixostat on the Pharmacokinetics of TheophyllineCompletedNCT06189404Phase 1
- A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial FoldsCompletedNCT05106751Phase 4
- A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese SubjectsCompletedNCT06040372Phase 1
- Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo TransferCompletedNCT05130125
- A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)CompletedNCT02627963Phase 3
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted before AVEO Pharmaceuticals, Inc. became part of LG Chem
- A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular CarcinomaTerminatedNCT03970616Phase 1/2
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted before AVEO Pharmaceuticals, Inc. became part of LG Chem
- A Phase 1 Study of AV-380 in Healthy SubjectsCompletedNCT04815551Phase 1
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted before AVEO Pharmaceuticals, Inc. became part of LG Chem
- Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline ContouringCompletedNCT04886544Not applicable
- A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)CompletedNCT03842267Phase 3
- A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.CompletedNCT04738019
- Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes MellitusStatus unknownNCT05281029
- To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in EuropeCompletedNCT04732793Not applicable
- Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female SubjectsCompletedNCT04966325Early Phase 1
- Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy AdultsCompletedNCT04886050Phase 1
- Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCCCompletedNCT03136627Phase 1/2
Sponsor listed in the registry: AVEO Pharmaceuticals, Inc. · First submitted before AVEO Pharmaceuticals, Inc. became part of LG Chem
- A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01025-CL in Healthy SubjectsStatus unknownNCT04730050Phase 1
- Efficacy and Safety of LC51-0255 in Subjects With Ulcerative ColitisWithdrawnNCT04096573Phase 2
- Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mgStatus unknownNCT05105698Phase 1
- To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area.TerminatedNCT04299295Not applicable
- A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT02746380Phase 3
Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem